Health-Care M&A Takes Center Stage With Mylan-Pfizer, Exact-Genomic Deals

The video discusses Pfizer's strategic deal with Mylan to enhance scale and geographic reach, addressing pricing pressures in the pharmaceutical industry. Mylan's financial struggles and leadership changes are highlighted, alongside the Genomic Health and Exact Sciences merger, emphasizing the importance of geographic expansion. The video concludes with insights into current market trends and the ongoing M&A cycle.

What recent trends are analysts observing in the healthcare sector?

What role does geographic reach play in the success of pharmaceutical companies?